Company: PHR
Filing Date: 2025-12-09
Form Type: 10-Q
Source: 0001412408-25-000132
Chunk: 155

Company: Phreesia, Inc.
Filing Date: 2025-12-09
Form: 10-Q
Item: Part I, Item 8
Chunk 155
---
31, 2025 and 2024, amortization expense related to capitalized internal-use software was $9,690 and $7,441, respectively.(d) Intangible assets and goodwill

20

The following presents the details of intangible assets as of October 31, 2025 and January 31, 2025:Useful Life (years)October 31, 2025January 31, 2025Acquired technology5 to 7$9,310 $9,310 Customer relationship7 to 1517,940 17,940 License156,200 6,200 Trademarks153,100 3,100 Total intangible assets, gross carrying value$36,550 $36,550 Less: accumulated amortization(11,018)(8,407)Net carrying value$25,532 $28,143 The weighted average remaining useful life for acquired technology in years was 4.4 and 5.1 as of October 31, 2025 and January 31, 2025, respectively. The remaining useful life for customer relationships in years was 11.0 and 11.6 as of October 31, 2025 and January 31, 2025, respectively. The remaining useful life for the license to the Patient Activation Measure ("PAM"®) in years was 11.1 and 11.8 as of October 31, 2025 and January 31, 2025, respectively. The remaining useful life for the trademarks in years was 12.8 and 13.5 as of October 31, 2025 and January 31, 2025, respectively.Amortization expense associated with intangible assets for the nine months ended October 31, 2025 and 2024, was $2,611.The estimated amortization expense for intangible assets for the next five years and thereafter was as follows as of October 31, 2025:October 31, 20252026 (Remaining three months)$840 Fiscal year ending January 31,20273,157 20283,157 20293,057 2030 - thereafter15,321 Total$25,532 There were no changes to the Company's goodwill balance during the nine months ended October 31, 2025. The Company did not record any impairments of goodwill during the three and nine months ended October 31, 202